APA (7th ed.) Citation

L, C., G, A., NV, D., L, R., AB, I., AS, C., . . . K, S. (2018). CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2. The Journal of clinical investigation, 128(1), 446. https://doi.org/10.1172/JCI90793

Chicago Style (17th ed.) Citation

L, Chen, et al. "CRISPR-Cas9 Screen Reveals a MYCN-amplified Neuroblastoma Dependency on EZH2." The Journal of Clinical Investigation 128, no. 1 (2018): 446. https://doi.org/10.1172/JCI90793.

MLA (9th ed.) Citation

L, Chen, et al. "CRISPR-Cas9 Screen Reveals a MYCN-amplified Neuroblastoma Dependency on EZH2." The Journal of Clinical Investigation, vol. 128, no. 1, 2018, p. 446, https://doi.org/10.1172/JCI90793.